Imperial Petroleum Inc.
DE ˙ DB ˙ MHY3894J1872
42,12 € ↓ -0,56 (-1,32%)
2019-07-30
DEL PRIS
SecurityDE:AR2 / Imperial Petroleum Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership160,940 shares
Latest Disclosed Value $ 688,823
Citadel Advisors Llc ownership in AR2 / Imperial Petroleum Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 160,940 shares of Imperial Petroleum Inc. (DE:AR2) valued at $688,823 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 62,721 shares of Imperial Petroleum Inc.. This represents a change in shares of 156.60% during the quarter. The current value of the position is $6,779,598 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AR2) in the form of stock options. The firm currently holds call options representing 220,900 of underlying shares valued at $945,452 USD and put options representing 90,300 of underlying shares valued at $386,484 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:AR2 / Imperial Petroleum Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMPERIAL PETE COM NEW Y3894J187 160,940 98,219 156.60 689 203.08 0.0001
2026-02-17 2025-12-31 13F IMPERIAL PETE COM NEW Y3894J187 62,721 -117,428 -65.18 227 -73.64 0.0000
2025-11-14 2025-09-30 13F IMPERIAL PETE COM NEW Y3894J187 180,149 54,126 42.95 861 121.91 0.0001
2025-08-14 2025-06-30 13F IMPERIAL PETE COM NEW Y3894J187 126,023 -59,174 -31.95 388 -14.35 0.0001
2025-05-15 2025-03-31 13F IMPERIAL PETE COM NEW Y3894J187 185,197 -165,210 -47.15 454 -57.02 0.0001
2025-02-14 2024-12-31 13F IMPERIAL PETE COM NEW Y3894J187 350,407 120,519 52.43 1,055 10.48 0.0002
2024-11-14 2024-09-30 13F IMPERIAL PETE COM NEW Y3894J187 229,888 171,861 296.17 954 324.00 0.0002
2024-08-14 2024-06-30 13F IMPERIAL PETE COM NEW Y3894J187 58,027 47,877 471.69 225 625.81 0.0000
2024-05-15 2024-03-31 13F IMPERIAL PETE COM NEW Y3894J187 10,150 8,610 559.09 32 675.00 0.0000
2024-02-14 2023-12-31 13F IMPERIAL PETE COM NEW Y3894J187 1,540 -160 -9.41 4 100.00 0.0000
2023-11-14 2023-09-30 13F IMPERIAL PETE COM NEW Y3894J187 1,700 1,700 3 0.0000
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 0 -4,346,050 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 4,346,050 3,792,085 684.54 201,352 1,390.83 0.0923
2019-05-15 2019-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 553,965 348,387 169.47 13,506 360.96 0.0067
2019-02-14 2018-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 205,578 -114,994 -35.87 2,930 -39.87 0.0016
2018-11-13 2018-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 320,572 86,480 36.94 4,873 24.06 0.0022
2018-08-14 2018-06-30 13F/A-1 ARRAY BIOPHARMA Cmn 04269X105 234,092 -883,514 -79.05 3,928 -78.46 0.0019
2018-08-10 2018-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 234,092 -883,514 3,928
2018-05-14 2018-03-31 13F/A-1 ARRAY BIOPHARMA Cmn 04269X105 1,117,606 -231,679 -17.17 18,240 5.62 0.0100
2018-05-11 2018-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 1,117,606 -231,679 18,240
2018-02-09 2017-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 1,349,285 -1,449,940 -51.80 17,270 -49.84 0.0105
2017-11-09 2017-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 2,799,225 1,805,347 181.65 34,430 313.87 0.0264
2017-08-11 2017-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 993,878 25,308 2.61 8,319 -3.93 0.0070
2017-05-12 2017-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 968,570 907,620 1,489.12 8,659 1,515.49 0.0079
2017-02-10 2016-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 60,950 -856,115 -93.35 536 -91.34 0.0005
2017-01-31 2016-09-30 13F/A-1 ARRAY BIOPHARMA Cmn 04269X105 917,065 -861,696 -48.44 6,190 -2.24 0.0062
2016-11-10 2016-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 917,065 6,190
2017-01-31 2016-06-30 13F/A-1 ARRAY BIOPHARMA Cmn 04269X105 1,778,761 1,778,761 292.32 6,332 231.00 0.0071
2016-08-12 2016-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 1,778,761 6,332
2016-05-13 2016-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 0 -453,393 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 ARRAY BIOPHARMA Cmn 04269X105 453,393 256,897 130.74 1,913 113.50 0.0021
2016-02-12 2015-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 453,393 1,913
2015-11-16 2015-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 196,496 -18,786 -8.73 896 -42.31 0.0009
2015-08-14 2015-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 215,282 -78,835 -26.80 1,553 -28.33 0.0014
2015-05-15 2015-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 294,117 269,148 1,077.93 2,167 1,736.44 0.0024
2015-02-17 2014-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 24,969 10,552 73.19 118 131.37 0.0001
2014-11-14 2014-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 14,417 -139,748 -90.65 51 -92.75 0.0001
2014-08-14 2014-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 154,165 146,625 1,944.63 703 1,908.57 0.0010
2014-05-15 2014-03-31 13F ARRAY BIOPHARMA Cmn 04269X105 7,540 -31,139 -80.51 35 -81.96 0.0000
2014-02-14 2013-12-31 13F ARRAY BIOPHARMA Cmn 04269X105 38,679 -131,907 -77.33 194 -81.72 0.0003
2013-11-14 2013-09-30 13F ARRAY BIOPHARMA Cmn 04269X105 170,586 -354,113 -67.49 1,061 -55.46 0.0016
2013-08-14 2013-06-30 13F ARRAY BIOPHARMA Cmn 04269X105 524,699 524,699 2,382 0.0041
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMPERIAL PETE COM NEW Call 220,900 32.35 945 56.46 n/a n/a n/a
2026-02-17 2025-12-31 13F IMPERIAL PETE COM NEW Call 166,900 10.75 604 -16.11 n/a n/a n/a
2025-11-14 2025-09-30 13F IMPERIAL PETE COM NEW Call 150,700 94.45 720 202.52 n/a n/a n/a
2025-08-14 2025-06-30 13F IMPERIAL PETE COM NEW Call 77,500 69.58 239 114.41 n/a n/a n/a
2025-05-15 2025-03-31 13F IMPERIAL PETE COM NEW Call 45,700 -12.12 112 -28.85 n/a n/a n/a
2025-02-14 2024-12-31 13F IMPERIAL PETE COM NEW Call 52,000 -29.44 157 -48.85 n/a n/a n/a
2024-11-14 2024-09-30 13F IMPERIAL PETE COM NEW Call 73,700 144.04 306 160.68 n/a n/a n/a
2024-08-14 2024-06-30 13F IMPERIAL PETE COM NEW Call 30,200 -86.77 117 -83.61 n/a n/a n/a
2024-05-15 2024-03-31 13F IMPERIAL PETE COM NEW Call 228,200 155.26 714 202.54 n/a n/a n/a
2024-02-14 2023-12-31 13F IMPERIAL PETE COM NEW Call 89,400 71.26 236 187.80 n/a n/a n/a
2023-11-14 2023-09-30 13F IMPERIAL PETE COM NEW Call 52,202 8.58 82 -44.59 n/a n/a n/a
2023-08-14 2023-06-30 13F IMPERIAL PETE COM NEW Call 48,078 148 n/a n/a n/a
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA Cmn Call 0 0 n/a n/a n/a
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F ARRAY BIOPHARMA Cmn Call 295,800 5.15 13,704 99.83 n/a n/a n/a
2019-05-15 2019-03-31 13F ARRAY BIOPHARMA Cmn Call 281,300 36.35 6,858 133.27 n/a n/a n/a
2019-02-14 2018-12-31 13F ARRAY BIOPHARMA Cmn Call 206,300 -5.41 2,940 -11.31 n/a n/a n/a
2018-11-13 2018-09-30 13F ARRAY BIOPHARMA Cmn Call 218,100 -3.20 3,315 -12.32 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ARRAY BIOPHARMA Cmn Call 225,300 88.06 3,781 93.40 n/a n/a n/a
2018-08-10 2018-06-30 13F ARRAY BIOPHARMA Cmn Call 225,300 3,781 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ARRAY BIOPHARMA Cmn Call 119,800 12.07 1,955 42.91 n/a n/a n/a
2018-05-11 2018-03-31 13F ARRAY BIOPHARMA Cmn Call 119,800 1,955 n/a n/a n/a
2018-02-09 2017-12-31 13F ARRAY BIOPHARMA Cmn Call 106,900 -5.65 1,368 -1.87 n/a n/a n/a
2017-11-09 2017-09-30 13F ARRAY BIOPHARMA Cmn Call 113,300 154.61 1,394 274.73 n/a n/a n/a
2017-08-11 2017-06-30 13F ARRAY BIOPHARMA Cmn Call 44,500 -16.67 372 -22.01 n/a n/a n/a
2017-05-12 2017-03-31 13F ARRAY BIOPHARMA Cmn Call 53,400 -51.67 477 -50.88 n/a n/a n/a
2017-02-10 2016-12-31 13F ARRAY BIOPHARMA Cmn Call 110,500 -19.64 971 4.63 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ARRAY BIOPHARMA Cmn Call 137,500 928 n/a n/a n/a
2016-11-10 2016-09-30 13F ARRAY BIOPHARMA Cmn Call 137,500 928 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F IMPERIAL PETE COM NEW Put 90,300 80.96 386 114.44 n/a n/a n/a
2026-02-17 2025-12-31 13F IMPERIAL PETE COM NEW Put 49,900 106.20 181 56.52 n/a n/a n/a
2025-11-14 2025-09-30 13F IMPERIAL PETE COM NEW Put 24,200 -63.93 116 -44.17 n/a n/a n/a
2025-08-14 2025-06-30 13F IMPERIAL PETE COM NEW Put 67,100 -61.37 207 -51.53 n/a n/a n/a
2025-05-15 2025-03-31 13F IMPERIAL PETE COM NEW Put 173,700 -46.69 426 -56.63 n/a n/a n/a
2025-02-14 2024-12-31 13F IMPERIAL PETE COM NEW Put 325,800 11.73 981 -19.01 n/a n/a n/a
2024-11-14 2024-09-30 13F IMPERIAL PETE COM NEW Put 291,600 131.06 1,210 147.44 n/a n/a n/a
2024-08-14 2024-06-30 13F IMPERIAL PETE COM NEW Put 126,200 119.48 490 173.18 n/a n/a n/a
2024-05-15 2024-03-31 13F IMPERIAL PETE COM NEW Put 57,500 20.04 180 42.06 n/a n/a n/a
2024-02-14 2023-12-31 13F IMPERIAL PETE COM NEW Put 47,900 26.39 126 113.56 n/a n/a n/a
2023-11-14 2023-09-30 13F IMPERIAL PETE COM NEW Put 37,900 16.77 60 -40.40 n/a n/a n/a
2023-08-14 2023-06-30 13F IMPERIAL PETE COM NEW Put 32,456 100 n/a n/a n/a
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA Cmn Put 0 0 n/a n/a n/a
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F ARRAY BIOPHARMA Cmn Put 339,100 516.55 15,711 1,071.59 n/a n/a n/a
2019-05-15 2019-03-31 13F ARRAY BIOPHARMA Cmn Put 55,000 25.00 1,341 113.88 n/a n/a n/a
2019-02-14 2018-12-31 13F ARRAY BIOPHARMA Cmn Put 44,000 -41.80 627 -45.43 n/a n/a n/a
2018-11-13 2018-09-30 13F ARRAY BIOPHARMA Cmn Put 75,600 -39.23 1,149 -44.94 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ARRAY BIOPHARMA Cmn Put 124,400 43.15 2,087 47.18 n/a n/a n/a
2018-08-10 2018-06-30 13F ARRAY BIOPHARMA Cmn Put 124,400 2,087 n/a n/a n/a
2018-05-14 2018-03-31 13F/A ARRAY BIOPHARMA Cmn Put 86,900 -18.56 1,418 3.81 n/a n/a n/a
2018-05-11 2018-03-31 13F ARRAY BIOPHARMA Cmn Put 86,900 1,418 n/a n/a n/a
2018-02-09 2017-12-31 13F ARRAY BIOPHARMA Cmn Put 106,700 -19.11 1,366 -15.78 n/a n/a n/a
2017-11-09 2017-09-30 13F ARRAY BIOPHARMA Cmn Put 131,900 0.92 1,622 48.26 n/a n/a n/a
2017-08-11 2017-06-30 13F ARRAY BIOPHARMA Cmn Put 130,700 26.89 1,094 18.78 n/a n/a n/a
2017-05-12 2017-03-31 13F ARRAY BIOPHARMA Cmn Put 103,000 75.47 921 78.49 n/a n/a n/a
2017-02-10 2016-12-31 13F ARRAY BIOPHARMA Cmn Put 58,700 0.69 516 30.96 n/a n/a n/a
2017-01-31 2016-09-30 13F/A ARRAY BIOPHARMA Cmn Put 58,300 394 n/a n/a n/a
2016-11-10 2016-09-30 13F ARRAY BIOPHARMA Cmn Put 58,300 394 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.